Related by context. All words. (Click for frequent words.) 86 Biologics License Application BLA 75 supplemental Biologics License Application 75 Marketing Authorization Application 74 sBLA 73 New Drug Application 72 Biologic License Application BLA 72 Biologic License Application 71 Marketing Authorization Application MAA 71 Biological License Application 70 BLA submission 70 NDA submission 69 Marketing Authorisation Application 68 FDA Approvable Letter 68 Complete Response 67 sNDA 67 application sNDA 67 Premarket Approval Application 67 BENLYSTA 67 BLA filing 66 Application BLA 66 Marketing Authorization Applications 66 Orathecin 66 Premarket Approval PMA 66 IND Investigational New 66 supplemental biologics 65 Drug Submission 65 FDA approvable letter 65 NEBIDO 65 FDA Complete Response 65 Pivotal Phase III 65 Marketing Authorisation Application MAA 65 FDA Accepts 65 prGCD 64 Civacir 64 JOULFERON 64 NDA Submission 64 StaphVAX R 64 Intermezzo ® NDA 64 Clinical Trial Application 64 registrational 64 Files Investigational 64 Investigational Device Exemption 64 FOLOTYN ® 64 Cellegesic 64 Exelbine 64 lorcaserin NDA 63 oral ridaforolimus 63 GRAS notification 63 Fodosine 63 taliglucerase alfa 63 PREOS R 63 Omigard 63 Exelbine NDA 63 PMA submission 63 NEBIDO R 63 ruxolitinib 63 IND submission 63 PREOS 62 Biologics Licensing 62 PIX# trial 62 Marqibo 62 Voraxaze 62 Nabi HB Intravenous 62 ATryn R 62 rolling Biologics License 62 velaglucerase alfa 62 CIP TRAMADOL ER 62 Contrave NDA 61 LibiGel ® 61 Acetavance 61 T Pred 61 Complete Response letter 61 MONOVISC 61 Market Approval PMA 61 alvimopan 61 OFIRMEV 61 REPLAGAL 61 sNDA filing 61 liver resection surgeries 61 octreotide implant 61 MAA submission 61 SYCREST 61 MK #B 61 peginesatide 61 Investigational 61 GTC recombinant human 61 DR Cysteamine 61 BLOOM DM 61 NDA resubmission 61 Orphan Drug Designation 61 Renvela 61 balsalazide tablet 61 Orphan Drug designation 61 Act PDUFA date 61 UPLYSO 61 Orphan Drug Status 61 Junovan 61 Marketing Authorization 61 vinorelbine emulsion 61 ZEGERID Capsules 61 APF# NDA 61 Fast Track designation 61 torezolid phosphate 61 Acetavance TM 61 submitted supplemental Biologics 61 ZALBIN 60 PLK1 SNALP 60 PROVENGE ® 60 BRILINTA 60 vilazodone 60 Premarket Approval 60 Supplemental Biologics License Application 60 BEMA Fentanyl 60 ANDA containing 60 VALSTAR 60 ANTEGREN 60 Fast Track Status 60 ATryn ® 60 License Application sBLA 60 phase IIb clinical 60 severe hypercholesterolemia 60 INDs 60 Priority Review 60 Rhucin ® 60 Clevudine 60 LibiGel NDA 60 ADVEXIN 60 ZEGERID Chewable Tablets 60 fidaxomicin 60 Zalbin 60 Investigational Device Exemption IDE 60 eprodisate KIACTA TM 60 Marketing Authorisation 60 Orphan Drug status 60 Rhucin R 60 ULTRASE 60 Phase III Clinical Trial 60 Approvable Letter 60 Tezampanel 60 indiplon capsules 60 clofarabine 60 ONCONASE 60 IV acetaminophen 60 Market Authorization Application 60 Zelrix 60 ONGLYZA ™ 60 Phase III clinical trials 60 Evoltra ® 60 L MTP PE 60 HepaGam B 60 Dacogen injection 59 Dalbavancin 59 Levoleucovorin 59 highly purified pasteurized 59 refractory chronic lymphocytic 59 VISICOL R 59 Oracea TM 59 Zenpep 59 pralatrexate 59 Glybera R 59 Accelerated Approval 59 Icatibant 59 ATPace TM 59 Completes Patient Enrollment 59 ANDAs 59 Dyloject TM 59 Restanza 59 FACTIVE R gemifloxacin 59 Personalized Immunotherapy 59 granted Ortec 59 proprietary transdermal patch 59 Prestara TM 59 CLIA waiver 59 Submits Supplemental 59 KRYSTEXXA TM pegloticase 59 hoFH 59 BENLYSTA ® 59 Ceplene 59 Announces Tentative Approval 59 IIa trial 59 PDUFA date 59 Orphan Drug designations 59 RELISTOR ® 59 Phenoptin 59 Biologics License Applications 59 Soliris TM eculizumab 59 tiapamil 59 linaclotide 59 apaziquone 59 Release Capsules 59 faropenem 59 dalbavancin 59 MOZOBIL 59 Zerenex 59 Allovectin 7 r 59 testosterone gel LibiGel 59 silodosin 59 Preotact 59 RIGScan CR 59 ixabepilone 59 sNDAs 59 Camvia 59 DPX Survivac 59 PANVAC VF 59 generation purine nucleoside 59 sNDA submission 59 pivotal Phase III 59 orphan designation 59 Linjeta TM 59 Application MAA 59 EFAPROXYN 59 Corlux 59 rThrombin 59 Calcium Acetate 59 Plicera 59 ridaforolimus 59 FIRAZYR 59 TRANSDUR Sufentanil 59 Luveniq 58 Fast Track designations 58 Emezine 58 VIVITROL ® 58 CRMD# 58 intravenous acetaminophen 58 StaphVAX 58 Augment Injectable 58 BYDUREON 58 Virulizin R 58 Phase III clinical 58 Somatuline R Autogel R 58 tafamidis 58 methylnaltrexone 58 Phase IIb clinical 58 Ereska 58 Phase IIb Clinical Trial 58 LymphoStat B TM 58 Raptiva R 58 Initiates Phase II 58 Rhucin 58 GATTEX TM 58 CERVARIX R 58 Advexin 58 Japanese Encephalitis vaccine 58 Phase IIIb clinical 58 Intermezzo R 58 virus HCV protease inhibitor 58 Jevtana 58 mesylate tablets 58 cinacalcet HCl 58 Zenvia ™ 58 Panzem R 58 Fast Track Designation 58 Urocidin 58 Mutual Recognition Procedure 58 confirmatory Phase 3 58 Firazyr 58 Surfaxin LS 58 Phase IIB 58 Allovectin 7 R 58 Approvable letter 58 ALN PCS 58 Soliris eculizumab 58 MyVax R 58 pegloticase 58 ibuprofen Injection 58 BLA 58 Pivotal Phase 58 DAVANAT R 58 k Premarket Notification 58 Tostrex 58 Esbriet pirfenidone 58 DAVANAT ® 58 DASISION 58 Vilazodone 58 Evoltra 58 Phase Ib 58 SILENOR TM 58 ATryn ® GTC recombinant 58 Lenocta 58 Pruvel 58 Iluvien ® 58 ORENCIA R 58 Amoxicillin PULSYS 58 FavId 58 BRIM3 58 Neuromodulation System 58 PDUFA Date 58 methylnaltrexone bromide 58 NUVIGIL 58 SUMAVEL 58 Allovectin 7 58 BLAs 58 PhosLo 58 Augment Bone Graft 58 oral prodrug 58 TELINTRA 58 Alvesco R 58 Stavzor 58 Clolar 58 Vion Pharmaceuticals 58 submit Biologics License 58 Stimuvax R 58 Saforis 58 successfully commercialize Iluvien 58 Pirfenidone 58 IND Application 58 JAK inhibitor 58 Telatinib 58 ENRICH trial 58 novel histone deacetylase 58 lymphoma CTCL 58 teduglutide 58 granulated mesalamine 58 dirucotide 58 Clofarabine 58 Cimzia ® 58 PDE4 inhibitor 58 OvaRex R 58 ROTATEQ 58 Fortigel 58 Lenocta TM 58 Complete Response Letter 58 BYETTA ® 58 RECOTHROM R 57 Staphylococcus aureus Polysaccharide Conjugate 57 PDX pralatrexate 57 OvaRex ® MAb 57 Nasdaq PGNX today 57 telavancin NDA 57 Phase IIa trial 57 liprotamase 57 nasal calcitonin product 57 Combidex 57 Sanctura XR 57 Phase 2b clinical 57 Pivotal Trial 57 oral methylnaltrexone 57 PROMACTA ® 57 Velaglucerase Alfa 57 L BLP# 57 RSR# 57 Drug Submission NDS 57 Tarceva TM 57 novel emulsion formulation 57 alogliptin 57 human C1 inhibitor 57 markets HP Acthar 57 Prostate AdenoCarcinoma Treatment 57 Telavancin 57 Nebido 57 Exocrine Pancreatic Insufficiency 57 Phase Ib study 57 Trofex 57 Ketotransdel 57 PNP inhibitor 57 PMA Supplement 57 Archexin 57 oral calcitonin 57 KALBITOR ® 57 Preotact R 57 BLP# Liposome Vaccine 57 ZEVALIN ® 57 Onconase 57 satraplatin 57 SFDA approval 57 Phase 1a clinical 57 GAMMAGARD 57 HP Acthar Gel repository 57 humanized anti 57 HepeX B TM 57 Oral Calcitonin 57 Thelin TM 57 Inhalation Aerosol 57 SPRYCEL ® 57 cutaneous T 57 Omigard TM 57 bazedoxifene 57 registrational trial 57 trastuzumab DM1 T DM1 57 Initiate Clinical Trial 57 Amigal 57 Insegia 57 approvable letters 57 Phase 2a clinical trials 57 Submits NDA 57 Romiplostim 57 Azedra 57 zileuton CR 57 ONCONASE R 57 IMPACT IMmunotherapy 57 Drug Applications ANDAs 57 k premarket 57 Polymer Microspheres 57 HCV protease inhibitor 57 LUVENIQ 57 miconazole Lauriad R 57 Kynapid 57 GTC recombinant form 57 ponatinib 57 TAXUS Element Stent System 57 Onco TCS 57 Presents Positive 57 TYZEKA 57 maribavir 57 Keppra ® XR 57 Mylan Receives Approval 57 Drug Application 57 SEBIVO 57 Apricus Bio 57 confirmatory Phase III 57 THALOMID 57 Impax ANDA 57 Riquent 57 AzaSite Plus 57 Vitaros 57 romiplostim 57 IND CTA 57 CryoSeal FS System 57 omacetaxine 57 Vascular Wrap TM 57 subcutaneous formulation 57 adecatumumab MT# 57 ZADAXIN ® 57 albinterferon alfa 2b 57 Bronchitol 57 Entereg alvimopan 57 MOVIPREP R 57 NUEDEXTA ™ 57 Targretin capsules 57 Centralized Procedure 57 Q#IR 57 Ceflatonin 57 Ceplene TM 57 ZOLINZA 57 Phase lll 57 LUCASSIN 57 thymalfasin 57 Onalta ™ 57 ITAX 57 acyclovir Lauriad R 57 LEVADEX TM 57 Evoltra TM 57 VIAject R 57 CINTREDEKIN BESUDOTOX 57 Bazedoxifene 57 PROGENSA R 57 celgosivir 57 Zensana 57 Rhucin ® recombinant 57 OLpur TM H2H 57 PROVENGE sipuleucel T 57 RANK Ligand inhibitor 57 histamine dihydrochloride 57 forodesine 57 Premarket Notification 56 Mozobil 56 NEUMUNE 56 NitroMist TM 56 EOquin 56 Granted Orphan Drug 56 acyclovir Lauriad ® 56 Extended Release Capsules 56 OMP designation 56 YONDELIS 56 Anturol TM 56 ENTEREG ® 56 ecallantide 56 XL# anticancer compounds 56 Aurexis 56 Xcytrin R 56 SILENOR 56 BEXXAR 56 Cethromycin 56 eltrombopag 56 lucinactant 56 Anturol ® 56 Amitiza 56 LIALDA 56 eniluracil 56 investigational humanized monoclonal antibody 56 CONBRIZA 56 Trizytek 56 Pennsaid R 56 Rescula 56 dose escalation clinical 56 CORTOSS 56 oxymorphone ER 56 Silenor ® doxepin 56 M Enoxaparin 56 Zingo TM 56 PrevOnco 56 tolevamer 56 Fortical R 56 ISTODAX 56 Granulocyte Colony Stimulating Factor 56 Promacta 56 phase IIb trial 56 Panzem R NCD 56 phase IIa 56 PrevOnco ™ 56 Sular formulation 56 Phase III Pivotal 56 interferon gamma 1b 56 Velac 56 Initiates Enrollment 56 octreotide acetate 56 SNT MC# 56 file INDs 56 Adventrx 56 faropenem medoxomil 56 USFDA approval 56 Abstral 56 Initiate Phase 56 Cinryze TM 56 Pralatrexate 56 Clolar ® 56 Bonefos 56 daily tramadol 56 Phase III pivotal 56 EGRIFTA TM 56 IMVAMUNE R 56 TOCOSOL Paclitaxel 56 Nasdaq VRTX 56 Pixuvri 56 zolpidem tartrate sublingual tablet 56 submitted Biologics License 56 cell lymphoma CTCL 56 voclosporin 56 COLAZAL R 56 Pivotal Clinical Trial 56 Dyloject 56 Multiferon R 56 GLP toxicology studies 56 Cloretazine ® 56 DC Bead 56 initiated Phase Ib 56 ISO Vorin TM 56 Phase Ib II 56 CoFactor 56 Imvamune 56 IND 56 OrCel R 56 ELADUR 56 XiDay 56 TRISENOX ® 56 ISENTRESS raltegravir 56 Zenvia TM 56 AnGes 56 Viviant 56 Somatuline Autogel 56 NYSE Amex PTN 56 Entereg TM 56 Pegloticase 56 COMFORT II 56 Frova ® 56 orBec 56 ospemifene 56 PEG SN# 56 Febuxostat 56 OrCel ® 56 Cleviprex TM clevidipine 56 GENERIC SILDENAFIL SOFT Generic 56 Trelstar R 56 Paragraph IV certifications 56 Urokinase 56 Gestiva TM 56 AVASTIN 56 Troxatyl 56 Elagolix 56 Zolpimist 56 Genasense ® oblimersen 56 mesylate tablets approved 56 Expedited Review 56 Dapagliflozin 56 dextromethorphan quinidine 56 sapropterin dihydrochloride 56 NASDAQ PGNX 56 FOLOTYN 56 Raptiva ® 56 Phase IIb clinical trials 56 QNEXA 56 Phase 2b trial 56 Joulferon 56 investigational pan BCR 56 AERx iDMS 56 NPSP# 56 SNS# T 56 OncoVEX 56 autologous cellular immunotherapy 56 SUCCEED trial 56 Submits Biologics License Application 56 ANDA 56 OMAPRO ™ 56 Rotarix ® 56 NeuroSTAT ® 56 SPARLON 56 Adenuric R 56 Cimzia TM 56 Mometasone Furoate 56 ocular formulation 56 crofelemer 56 APF# 56 Xcellerated T Cells 56 Zenvia Phase III 56 ACUROX 56 ILUVIEN ® 56 AP# [003] 56 CIP ISOTRETINOIN 56 phase IIa clinical 56 Zytiga 56 novel oral anticoagulant 56 Submits Investigational 56 sublingual tablets 56 Plenaxis R 56 Genasense ® 56 vinflunine 56 Davanat 56 Silenor NDA 56 Receives Approvable Letter 56 LEUKINE 56 TRANSDUR Bupivacaine 56 Anidulafungin 56 human lactoferrin 56 Kuvan TM sapropterin 56 OSMOPREP 56 rhThrombin 56 Loramyc 55 Ciclesonide 55 Receives Orphan Drug Designation 55 Phase 1b Clinical Trial 55 LEVADEX ™ 55 TREANDA 55 Fx #A 55 Ampligen r 55 New Drug IND 55 Pivotal Study 55 initiate Phase IIb 55 ® decitabine 55 Aloxi ® 55 Ferumoxytol 55 sevelamer carbonate 55 ZEGERID Powder 55 Topical Interferon Alpha 2b 55 SinuNase 55 HepeX B 55 TYGACIL 55 Entereg R 55 PULSYS 55 investigational 55 Bioral Amphotericin B 55 Kamada AAT 55 ONCASPAR 55 VEGF Trap 55 Enjuvia 55 Kuvan R 55 Phase 2b Clinical Trial 55 Ruconest 55 ENLIGHT 55 investigational hepatitis B 55 Phase #b/#a clinical 55 Drug Applications NDAs 55 Vidaza R 55 Initiates Phase III 55 Esbriet ® 55 ANDA filings 55 ELIQUIS 55 NM# [001] 55 Phase IIb Trial 55 Ventavis 55 Tamibarotene 55 GlycoPEG GCSF 55 ambrisentan 55 PRECISE trial 55 OLEPTRO 55 FUSILEV ® 55 Loramyc R 55 Safe GRAS status 55 Orphan Status 55 rasagiline tablets 55 valopicitabine 55 rNAPc2 55 Barr ANDA 55 DRAXIMAGE 55 highly selective adenosine 55 XIAFLEX ™ 55 REMOXY NDA 55 Replagal 55 Paragraph IV 55 CIMZIA TM 55 NASDAQ INGN 55 preclinical toxicology 55 nanofiltered plasma derived 55 Initiates Clinical 55 IMA# 55 initiated Phase 1b 55 arsenic trioxide injection 55 MAGE A3 ASCI 55 elotuzumab 55 ketolide antibiotic 55 commercialize toremifene 55 Phase 2b study 55 investigational oral hepatitis C 55 Viramidine 55 IND enabling 55 Argatroban 55 alvespimycin 55 Amrubicin 55 Zavesca r 55 SEASONIQUE TM 55 Cimzia certolizumab pegol 55 KIF6 Genotyping Assay 55 Marketing Approval PMA 55 N acetylgalactosamine 6 55 DPP4 inhibitor 55 OvaDx 55 DAYTRANA TM 55 Loramyc ® 55 IL# PE#QQR 55 aztreonam lysine 55 Loramyc ™ 55 Androxal TM 55 SparVax TM 55 pediatric exclusivity 55 Augment TM 55 R sipuleucel T 55 Thrombin topical Recombinant 55 Meets Primary Endpoint 55 iChem VELOCITY 55 ALN TTR 55 alglucosidase alfa 55 Advagraf 55 novel MetAP 2 55 Belinostat 55 Surfaxin lucinactant 55 MEND CABG II 55 Xanafide 55 Veronate 55 TransVax TM 55 sitaxsentan sodium 55 PROSTASCINT R 55 Pafuramidine 55 bardoxolone 55 Stedivaze 55 CLIRS trial 55 ongoing Phase 1b 55 REPEL CV 55 NOXAFIL 55 eliglustat tartrate 55 Phase IIb III 55 vernakalant iv 55 naproxen esomeprazole magnesium 55 budesonide MMX 55 METOZOLV ODT 55 Phase #b/#a trial 55 sapacitabine 55 Metformin GR 55 pixantrone NDA 55 DIFICID ™ 55 LidoPAIN SP 55 OraTest 55 Phase 1b trial 55 Patient Enrollment 55 Hematide ™ peginesatide 55 CIMZIA r 55 lintuzumab SGN 55 inhaled AAT 55 Actemra tocilizumab 55 SUMAVEL DosePro 55 Vectibix panitumumab 55 CryoSeal 55 novel trazodone formulation 55 Recombinant Human 55 rhC1INH 55 FDA Approval 55 Amigal TM 55 GRALISE 55 Receives Tentative FDA 55 HoFH 55 Cladribine Tablets 55 Phase IIb trials 55 OMNARIS HFA 55 Roflumilast 55 Hematide ™ 55 Dupuytren Contracture 55 generic Copaxone 55 Drug Eluting Stent System 55 ONTAK 55 CHMP recommendation 55 Sumatriptan Succinate 55 axitinib 55 MAXY alpha 55 INCB# [001] 55 Submits Response 55 Locteron ® 55 Genz # 55 MKC# MT 55 Linjeta 55 Phase IIb 55 Rotarix R 55 Xibrom QD 55 Romidepsin 55 STELARA TM 55 sumatriptan injection 55 Ranexa R 55 orBec R 55 SUTENT ® 55 Sprycel dasatinib 55 Ixempra 55 phase IIb 55 Increlex R 55 Orapred ODT 55 diarrhea predominant irritable 55 Plenaxis TM 55 CDP# 55 MEPACT 55 PhosLo R 55 Intermezzo ® 55 sumatriptan DosePro 55 SinuNase TM 55 product BioThrax ® 55 H#N# VLP vaccine 55 Chemophase 55 RIGScan ™ 55 GEM #S 55 AZILECT R 55 PXD# 55 amrubicin 55 docetaxel Taxotere ® 55 vemurafenib 55 HuMax CD4 55 Renvela ® 55 eprodisate Fibrillex TM 55 TSX SHQ 55 Increlex TM 55 Exalgo TM 55 SEASONALE R 55 pantoprazole sodium 55 ARRY # 55 Xenazine ® 55 Vernakalant 55 Immune Globulin Human 55 Octreolin 55 Phase 2b 55 Protexia ® 55 Receives Positive Opinion 55 Genasense 54 Trobalt 54 INCB# [002] 54 Dextofisopam 54 Investigational Compound 54 Product Monograph 54 Phase III Clinical Trials 54 EvaMist TM 54 lomitapide 54 oral taxane 54 ABL inhibitor 54 OPAXIO 54 Octreotide 54 molecular imaging radiopharmaceutical 54 pralatrexate injection folate analogue 54 TRISENOX 54 ARIKACE 54 Zorbtive TM 54 Opterone R 54 CEQ# 54 TKB# 54 ELAPRASE 54 Neurodex 54 intravenous AAT 54 eCTD format 54 blood thinner rivaroxaban 54 novel bactericidal 54 Nasdaq DVAX 54 EGRIFTA ™ 54 Sanvar R 54 Visian Toric ICL 54 Phase III Trial 54 IV APAP 54 fluvoxamine maleate 54 Relistor 54 cervical cancer vaccine Cervarix 54 Japanese Encephalitis Vaccine 54 Liprotamase 54 TBC# 54 Peginterferon alfa 2b 54 Release Tablets 54 Prestara 54 MBP# [001] 54 diabetic neuropathic pain 54 pralatrexate injection 54 carcinogenicity study 54 Valtropin 54 gabapentin enacarbil 54 investigational antiplatelet agent 54 Phase 2a Trial 54 ANDA submission 54 forodesine hydrochloride 54 SPD# 54 Phase III 54 Intravenous Hepatitis B 54 Proellex TM 54 nonclinical studies 54 Lymphoseek ® 54 pivotal Phase 54 registrational studies 54 Certican 54 Nexavar ® 54 corticotropin injection 54 MethyPatch 54 CLIA Waiver 54 metoprolol succinate 54 AMRIX 54 clevudine 54 FDA Orphan Drug 54 Fenoglide 54 OTC ZEGERID 54 Inhalation Solution 54 HGS ETR2 54 orally administered inhibitor 54 candidates bavituximab 54 Files IND 54 Testosterone Gel 54 FOSRENOL 54 Generic Version 54 PROVENGE 54 liposomal formulation 54 Nicotine Conjugate Vaccine 54 vernakalant oral 54 Lucanix R 54 Cetrorelix 54 CD# CEA 54 Brentuximab Vedotin SGN 54 Fentanyl TAIFUN R 54 IRX 2 54 VALSTAR R 54 Cinryze ™ 54 Aryplase 54 Asentar 54 antibody MAb 54 metastatic sarcomas 54 RAV# 54 Begins Dosing 54 Phase IIb trial 54 NerPharMa 54 GALNS 54 mifamurtide 54 Mepact 54 JZP 6 54 FDA Accelerated Approval 54 brentuximab 54 Oncoscience AG 54 Liberte TM 54 REG1 Anticoagulation System 54 dihydrochloride Phase 3 54 Ambrisentan 54 intranasal formulation 54 MyVax 54 Onrigin 54 anidulafungin 54 Xolegel 54 tezampanel NGX# 54 Strativa 54 HCl capsules 54 Horizant 54 deforolimus 54 TQT study 54 Ganciclovir 54 Phase 2a trial 54 Lamictal ODT 54 PROMACTA 54 Cintredekin Besudotox 54 Ustekinumab 54 Receives Fast Track 54 Firazyr ® 54 abiraterone acetate 54 Phase III HEAT 54 Orazol 54 GLP1 agonist 54 MGN# 54 Presents Preclinical 54 Glycopyrrolate 54 BioGlue ® 54 Teflaro 54 placebo controlled Phase 54 docetaxel Taxotere R 54 Metformin HCl 54 Nabi HB R 54 RELISTOR 54 MAXY G# 54 tamibarotene 54 THELIN 54 PRX # 54 capsule formulation 54 Nasdaq OPTR 54 Therapeutic Competitors Companies 54 Anturol 54 INKP 54 Intravenous Human 54 Genasense R